Oct 19 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:
SOBI ANNOUNCES REVISED FULL YEAR OUTLOOK AND ADVANCES PUBLICATION OF THE Q3 2025 FINANCIAL REPORT
SOBI Q3 REVENUE SEK 7,776 MILLION VS. IBES ESTIMATE SEK 7,907 MILLION
ADJUSTED EBITA MARGIN FOR Q3 2025 WAS 47 PER CENT
SOBI RECORDS SEK 6,612 M IMPAIRMENT CHARGE IN Q3 2025 FOR VONJO
REVISED FULL YEAR OUTLOOK FOR 2025, REVENUE IS NOW ANTICIPATED TO GROW BY A LOW DOUBLE-DIGIT PERCENTAGE AT CER
2025 ADJUSTED EBITA MARGIN IS ANTICIPATED TO BE IN MID-TO-HIGH 30'S PER CENT OF REVENUE
Source text: ID:nWkr6fBSnk
Further company coverage: SOBIV.ST
((Reuters.Briefs@thomsonreuters.com;))